Background
Methods
DNA constructs
Cell culture and stable transfectants
Fluorescence microscopy
Differentiation assay
Northern blot analysis and quantitative RT-PCR
Western blot analysis
Microarray analysis
Flow cytometry analysis of surface markers
Analysis of promoter sequences
Microarray data analysis
Results
Exogenous HMGA2 is localized to the nucleus
HMGA2 abolishes differentiation into the adipocytic lineage
Identification of transcriptional targets
Changes in HMGA2WTcells | Changes in HMGA2trunc cells | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Rank | Gene | Description | MA | qPCR | Rel. to EGFP* | Gene | Description | MA | qPCR | Rel. to EGFP* | |
a)
|
1
|
CXCL6
| Chemokine (C-X-C motif) ligand 6 | -8.4 | -6.7 | -2.2 |
CXCL6
| Chemokine (C-X-C motif) ligand 6 | -9.0 | -6.3 | -2.2 |
2
|
IL8
| Interleukin 8 | -7.5 | -7.1 | -6.4 |
HLA-DRA
| Major histocompatibility complex class II antigen DRA | -8.7 | -8.1 | -7.2 | |
3
|
CD24
| CD24 molecule | -7.1 |
HLA-DPA1
| Major histocompatibility complex class II antigen DPA1 | -8.0 | -6.8 | -5.5 | |||
4
|
C13orf33
| Chromosome 13 open reading frame 33 | -6.5 |
ChGn
| Chondroitin beta-1,4-N-acetylgalactosaminyltransferase | -6.5 | |||||
5
|
PTGES
| Prostaglandin E synthase | -6.3 |
PKIB
| cAMP-dependent protein kinase inhibitor 2 | -6,4 | -4.9 | -5.0 | |||
6
|
ChGn
| Chondroitin beta-1,4-N-acetylgalactosaminyltransferase | -5.6 |
IFI44L
| Interferon-induced protein 44-like | -6.2 | |||||
7
|
IL6
| Interleukin 6 | -5.5 |
LAMA4
| Laminin alpha chain | -6.2 | |||||
8
|
PDE4D
| cAMP-specific phosphodiesterase 4D | -5.2 |
SLC38A5
| Solute carrier family 38, member 5 | -6.0 | |||||
9
|
IL1RN
| Interleukin 1 receptor antagonist | -5.1 | -4.4 | -3.0 |
PTPRN2
| Protein tyrosine phosphatise, receptor type, N2 | -5.5 | |||
10
|
CES1
| Carboxylesterase 1 | -5.1 |
C13orf33
| Chromosome 13 open reading frame 33 | -5.4 | |||||
11
|
KIAA1644
| KIAA1644 protein | -5.0 | -3.4 | -1.7 | n/a | Similar to Wnt-1 inducible signalling pathway protein 1 | -5.4 | |||
12
|
SAMSN1
| SH3-SAM adaptor protein | -4.8 |
IL1B
| Interleukin1 beta | -5.3 | -4.3 | -2.2 | |||
13
|
SERPIND1
| Serpin peptidase inhibitor, clade D, member 1 | -4.7 |
F2RL1
| Coagulation factor II receptor-like 1 | -5.2 | |||||
14
|
FAM5C
| Familiy with sequence similarity 5,member C | -4.4 |
CD74
| CD74 antigen-associated invariant chain | -5.2 | -5.4 | -4.3 | |||
15
| n/a | Transcribed sequence FLJ 26764 | -4.3 |
IL1RN
| Interleukin 1 receptor antagonist | -5.2 | -5.2 | -3.8 | |||
b)
|
1
|
ZBED2
| Zinc finger BED domain-containing protein 2 | 5.3 | 4.5 | n/a | transcribed sequence FLJ33010 | 6.7 | |||
2
|
SHROOM2
| Shroom family member 2 | 4.6 |
CXCL12
| Chemokine (C-X-C motif) ligand 12 | 6.4 | 2.7 | 2.0 | |||
3
|
FGF13
| Fibroblast growth factor 13 | 4.5 | 4.6 | 5.6 |
PRSS7
| Serine protease 7 | 6.0 | |||
4
|
BAI3
| Brain-specific angiogenesis inhibitor 3 | 4.5 | 4.4 | 5.4 |
SULT1B1
| Sulfotransferase 1B1 | 5.8 | |||
5
|
PLXNA4
| Plexin A4 | 4.4 |
SSX1
| Synovial sarcoma, X breakpoint 1 | 4.9 | 9.6 | 10.2 | |||
6
|
LCP1
| Lymphocyte cytosolic protein 1 | 4.1 | 3.9 | 2.1 |
MMP3
| Matrix metalloproteinase-3 | 4.7 | |||
7
|
C20orf197
| Chromosome 20 open reading frame 197 | 4.0 |
CYB5R2
| Cytochrome b5 reductase 2 | 4.5 | |||||
8
|
G0S2
| G0/S switch 2 | 3.7 | 5.6 | 5.4 |
KISS1
| KiSS-1 metastasis-supressor | 4.5 | |||
9
|
HDAC9
| Histone deacetylase 9 | 3.7 | 1.5 |
EDN1
| Endothelin 1 | 4.5 | ||||
10
|
SIGLEC15
| Sialic acid binding Ig-like lectin 15 | 3.7 |
SYNE1
| Synaptic nuclear envelope protein 1 | 4.4 | |||||
11
|
HCLS1
| Hematopoietic cell-specific Lyn substrate 1 | 3.6 | 2.5 | 3.6 |
HAPLN1
| Hyaluronan and proteoglycan link protein 1 | 4.4 | |||
12
|
LOC646340
| similar to Ankyrin repeat domain-containing protein 18A | 3.6 | n/a | transcribed sequence FLJ35091 | 4.4 | |||||
13
|
GATA3
| GATA binding protein 3 | 3.5 | 3.6 | >10 | n/a | Similar to TATA box-binding protein-associated factor 1B | 4.3 | |||
14
|
SH3BGRL2
| SH3 domain binding glutamic acid-rich protein like 2 | 3.5 |
BAI3
| Brain-specific angiogenesis inhibitor 3 | 4.2 | 4.6 | 5.6 | |||
15
|
PDE4B
| cAMP-specific phospodiesterase 4B | 3.5 | n/a | Similar to cytochrome c oxidase I | 4.1 |
Transcriptional effects common to wild type and truncated HMGA2
Biological processes affected by over-expression of wild type and truncated HMGA2 | |
---|---|
Vascular development (4 of 66 up-regulated genes) | p = 0.039 |
Response to wounding (17 of 139 down-regulated genes) | p < 0.001 |
Signal transduction (40/139) | p < 0.001 |
Chemotaxis (11/139) | p < 0.001 |
Cytosolic calcium ion homeostasis (5/139) | p < 0.001 |
Phosphate transport (5/139) | p = 0.0017 |
Regulation of cell proliferation (11/139) | p = 0.0033 |
Cell migration (8/139) | p = 0.0057 |
Cell recognition (3/139) | p = 0.027 |
Epithelial cell differentiation (3/139) | p = 0.026 |
Wound healing (4/139) | p = 0.042 |
Biological processes affected by over-expression of wild type HMGA2
| |
Multi-cellular organismal development (20 of 84 up-regulated genes) | p = 0.0011 |
Response to hormone stimulus (4/84) | p = 0.0034 |
Regulation of signal transduction (7/84) | p = 0.022 |
Pyridine nucleotide biosynthetic process (3 of 99 down-regulated genes) | p = 0.0017 |
Steroid hormone receptor activity (3/99) | p = 0.0032 |
Negative regulation of transcription factor activity (3/99) | p = 0.0034 |
Positive regulation of transcription (7/99) | p = 0.0065 |
Response to external stimulus (8/99) | p = 0.042 |
Biological processes affected by over-expression of truncated HMGA2
| |
Regulation of transcription (61 of 258 up-regulated genes) | p < 0.001 |
Intracellular protein transport across a membrane (6/258) | p = 0.0032 |
Membrane organization and biogenesis (11/258) | p = 0.011 |
Ras protein signaling transduction (9/258) | p = 0.031 |
Regulation of cytoskeleton organization and biogenesis (4/258) | p = 0.042 |
Antigen processing and presentation (10 of 239 down-regulated genes) | p < 0.001 |
Multi-cellular organismal development (41/239) | p = 0.0021 |
Cell adhesion (16/239) | p = 0.019 |
Eye morphogenesis (3/239) | p = 0.035 |